Provectus Biopharmaceuticals Inc PVCT:OTCQB

RT Quote | Exchange | USD
Last | 05/20/22 EDT
0.0568quote price arrow up+0.0004 (+0.62%)
Volume
36,011
52 week range
0.04 - 0.08
Loading...
  • Open0.06
  • Day High0.06
  • Day Low0.0546
  • Prev Close0.0564
  • 52 Week High0.08
  • 52 Week High Date06/01/21
  • 52 Week Low0.04
  • 52 Week Low Date12/14/21

Key Stats

  • Market Cap23.82M
  • Shares Out419.45M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change3.18

KEY STATS

  • Open0.06
  • Day High0.06
  • Day Low0.0546
  • Prev Close0.0564
  • 52 Week High0.08
  • 52 Week High Date06/01/21
  • 52 Week Low0.04
  • 52 Week Low Date12/14/21
  • Market Cap23.82M
  • Shares Out419.45M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.19
  • YTD % Change3.18

RATIOS/PROFITABILITY

  • EPS (TTM)-0.01
  • P/E (TTM)-6.02
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-4.064M
  • ROE (TTM)-934.31%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-40.56%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Provectus Biopharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Provectus Biopharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing immunotherapy medicines for different diseases, based on a family of small molecules called halogenated xanthenes (HXs). Its lead HX molecule, rose bengal sodium (RBS). Its product pipeline includes PV-10 and PH-10. Its PV-10 is an investigational cancer immunotherapy administered by intralesional (IL) injection and an injectable formulation of cGMP (current Good...
Edward Pershing CPA
Chairman of the Board
Dominic Rodrigues
Vice Chairman of the Board
Timothy Scott Ph.D.
President
Bruce Horowitz
Chief Operating Officer, Director
Heather Raines
Chief Financial Officer
Eric Wachter Ph.D.
Chief Technology Officer
Address
10025 Investment Dr Ste 250
Knoxville, TN
37932-2664
United States

Top Peers

SYMBOLLASTCHG%CHG
NAVB
Navidea Biopharmaceuticals Inc
0.8154-0.0846-9.40%
TMBR
Timber Pharmaceuticals Inc
0.2606-0.0043-1.6233%
CYTH
Cyclo Therapeutics Inc
1.98-0.07-3.41%
ACUR
Acura Pharmaceuticals Inc
0.348-0.182-34.3396%
TRVN
Trevena Inc
0.2661+0.0205+8.35%
ZYNE
Zynerba Pharmaceuticals Inc
0.959-0.0293-2.9647%